logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9840550 B1

PDFFull Text
Date of Patent:
Dec. 12, 2017

Filed:

Oct. 01, 2013

Compounds for treating the remyelination blockade in diseases associated with the expression of herv-w envelope protein

Applicant:

Geneuro SA, Plan-les-Ouates, CH;

Inventors:

Hervé Perron, Saint Genis les Ollieres, FR;

Reza Firouzi, Sainte-Foy-les-Lyon, FR;

Patrick Küry, Düsseldorf, DE;

Raphaël Faucard, Mont-Saxonnex, FR;

Alexandra Madeira, Mont-Saxonnex, FR;

Julie Joanou, Rive de Gier, FR;

Assignee:

GENEURO S.A., Plan-les-Ouates, CH;

Attorney:

Oliff PLC

Primary Examiner:

Robert C Hayes

Int. Cl.
CPC ...
A61K 39/42 (2006.01); A61K 31/17 (2006.01); A61K 31/194 (2006.01); C07K 16/10 (2006.01); A61K 45/06 (2006.01); A61K 31/155 (2006.01); A61K 31/223 (2006.01); A61K 31/225 (2006.01); A61K 31/221 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1036 (2013.01); A61K 31/155 (2013.01); A61K 31/17 (2013.01); A61K 31/194 (2013.01); A61K 31/221 (2013.01); A61K 31/223 (2013.01); A61K 31/225 (2013.01); A61K 39/42 (2013.01); A61K 45/06 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01);
Abstract

The present invention deals with innovative compounds and compositions for preventing and/or treating a newly discovered detrimental mechanism, which blocks the endogenous myelin repair capacity of the adult nervous system (NS) in diseases associated with the expression of HERV-W envelope protein (ENV), in particular of its MSRV subtype.

Find Patent Forward Citations

Perron, Hervé. (2017). Compounds for treating the remyelination blockade in diseases associated with the expression of herv-w envelope protein (U.S. Patent No. 9840550). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9840550

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…